This compound is a protected synthetic peptide building block featuring a fluorenylmethoxycarbonyl (Fmoc) amino protecting group and a tert-butyl ester on the side chain. It is designed for use in solid-phase peptide synthesis to introduce a modified glutamic acid residue with an oxazolidine backbone.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 957780-56-2
Fmoc-Asp(Otbu)-Thr(Psime,Mepro)-OH
pharmaceutical intermediate
Fmoc-Lys(Boc)-Thr(Psime,Mepro)-OH
research compound
Fmoc-Ser(tBu)-Thr(Psi(Me,Me)pro)-OH
research compound
Fmoc-Gln(Trt)-Thr(Psi(Me,Me)pro)-OH
research compound
Fmoc-Asn(Trt)-Thr(Psime,Mepro)-OH
research compound
5-Bromo-6-methyl-1H-pyrrolo[2,3-b]pyridine
research compound
(2-Bromo-3-fluorophenyl)acetic acid
research compound
N-(4-Chlorophenyl)-1-methyl-1H-imidazole-4-carboximidamide
research compound
(4S,5R)-3-[(2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-5-[(2-methylpropan-2-yl)oxy]-5-oxopentanoyl]-2,2,5-trimethyl-1,3-oxazolidine-4-carboxylic acid
SIDKUUFAHNZJLW-VAQLEPBLSA-N
C[C@@H]1[C@H](N(C(O1)(C)C)C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)OCC2C3=CC=CC=C3C4=CC=CC=C24)C(=O)O
—